Coinfusion of dextrose-containing fluids and red blood cells does not adversely affect in vitro red blood cell quality

Transfusion

Volumn 54, Issue 8, 2014, Pages 2068-2076

  Keir, Amy K ^a   Hansen, Adele L ^a   Callum, Jeannie ^b,c   Jankov, Robert P ^a,d,e   Acker, Jason P ^a,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c CANADIAN BLOOD SERVICES   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROSE CONTAINING FLUID; GLUCOSE; HEMOGLOBIN; INFUSION FLUID; POTASSIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AGE; ARTICLE; BLOOD PUMP; CONTROLLED STUDY; COULTER COUNTER; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FUNCTION AND CHARACTERISTICS; ERYTHROCYTE PRESERVATION; ERYTHROCYTE QUALITY; ERYTHROCYTE STRUCTURE; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HEMOLYSIS; HUMAN; IN VITRO STUDY; INCUBATION TIME; IRRADIATION; MEAN CORPUSCULAR VOLUME; NEWBORN INTENSIVE CARE; NORMAL HUMAN;

BLOOD TRANSFUSION; DRUG EVALUATION, PRECLINICAL; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE INDICES; ERYTHROCYTES; GLUCOSE; HEMATOCRIT; HEMOGLOBINS; HEMOLYSIS; HUMANS; INTENSIVE CARE, NEONATAL; OSMOLAR CONCENTRATION; OSMOTIC FRAGILITY; POTASSIUM; PRACTICE GUIDELINES AS TOPIC; SODIUM CHLORIDE; SOLUTIONS;

EID: 84906224352     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12618     Document Type: Article

References (26)

1. Canadian Blood Services. Circular of Information: For the use of human blood components. Ottawa: Canadian Blood Services; 2013 [cited 2013 May 14]. Available from: www.blood.ca
2. Keir A, Callum J, Jankov RP,. Is it safe to co-infuse dextrose-containing fluids with red blood cells? J Paediatr Child Health 2013; 49: 687-691.
3. Stark MJ, Story C, Andersen C,. Effect of co-infusion of dextrose-containing solutions on red blood cell haemolysis during packed red cell transfusion. Arch Dis Child Fetal Neonatal Ed 2012; 97: F62-64.
4. Christensen RD, Ilstrup S,. Erythrocyte transfusions in neonates: is it safe to co-infuse dextrose-containing solutions? Arch Dis Child Fetal Neonatal Ed 2012; 97: F3.
5. Neu J, Walker WA,. Necrotizing enterocolitis. N Engl J Med 2011; 364: 255-264.
6. Mohamed A, Shah PS,. Transfusion associated necrotizing enterocolitis: a meta-analysis of observational data. Pediatrics 2012; 129: 529-540.
7. Kirpalani H, Zupancic JA,. Do transfusions cause necrotizing enterocolitis? The complementary role of randomized trials and observational studies. Semin Perinatol 2012; 36: 269-276.
8. El-Dib M, Narang S, Lee E, et al. Red blood cell transfusion, feeding and necrotizing enterocolitis in preterm infants. J Perinatol 2011; 31: 183-187.
9. Keir AK, Wilkinson D,. Question 1 * Do feeding practices during transfusion influence the risk of developing necrotising enterocolitis in preterm infants? Arch Dis Child 2013; 98: 386-388.
10. Williams AF,. Hypoglycaemia of the newborn: a review. Bull World Health Organ 1997; 75: 261-290.
11. Grunau RE, Whitfield MF, Petrie-Thomas J, et al. Neonatal pain, parenting stress and interaction, in relation to cognitive and motor development at 8 and 18 months in preterm infants. Pain 2009; 143: 138-146.
12. Brummelte S, Grunau RE, Chau V, et al. Procedural pain and brain development in premature newborns. Ann Neurol 2012; 71: 385-396.
13. Jankov RP, Roy RN,. Minimal haemolysis in blood co-infused with amino acid and dextrose solutions in vitro. J Paediatr Child Health 1997; 33: 250-252.
14. Levin E, Culibrk B, Gyongyossy-Issa MI, et al. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Transfusion 2008; 48: 2331-2337.
15. Fergusson DA, Hebert P, Hogan DL, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA 2012; 308: 1443-1451.
16. Hansen A, Yi QL, Acker JP,. Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions. Transfusion 2013; 53: 1772-1779.
17. Usry RT, Moore GL, Manalo FW,. Morphology of stored, rejuvenated human erythrocytes. Vox Sang 1975; 28: 176-183.
18. Stadnick H, Onell R, Acker JP, et al. Eadie-Hofstee analysis of red blood cell deformability. Clin Hemorheol Microcirc 2011; 47: 229-239.
19. Australian & New Zealand Society of Blood Transfusion Inc. Guidelines for the administration of blood products. Sydney: Australian & New Zealand Society of Blood Transfusion Inc.; 2011 [cited 2013 May 14]. Available from: http://www.anzsbt.org.au/publications/
20. van den Bos A, Wissink WM, Schattenberg AV, et al. Feasibility of a new in vitro approach to evaluate cellular damage following co-infusion of red blood cell concentrates and intravenous drug solutions. Clin Lab Haematol 2003; 25: 173-178.
21. Sowemimo-Coker SO,. Red blood cell hemolysis during processing. Transfus Med Rev 2002; 16: 46-60.
22. Hess JR, Sparrow RL, van der Meer PF, et al. Red blood cell hemolysis during blood bank storage: using national quality management data to answer basic scientific questions. Transfusion 2009; 49: 2599-2603.
23. Birch C, Hogan C, Mahoney G,. Co-administration of drugs and blood products. Anaesth Intensive Care 2001; 29: 137-140.
24. Noble TC, Abbott J,. Haemolysis of stored blood mixed with isotonic dextrose-containing solutions in transfusion apparatus. Br Med J 1959; 2: 865-866.
25. Jones JH, Kilpatrick GS, Franks EH,. Red cellaggregation in dextrose solutions. J Clin Pathol 1962; 15: 161-162.
26. Strautz RL, Nelson JM, Meyer EA, et al. Compatibility of ADSOL-stored red cells with intravenous solutions. Am J Emerg Med 1989; 7: 162-164.